...
首页> 外文期刊>Cases Journal >Interstitial pneumonitis associated with pegylated interferon-alpha 2a and ribavirin for chronic hepatitis C infection: a case report
【24h】

Interstitial pneumonitis associated with pegylated interferon-alpha 2a and ribavirin for chronic hepatitis C infection: a case report

机译:聚乙二醇干扰素-α2a和利巴韦林联合治疗慢性丙型肝炎的间质性肺炎:病例报告

获取原文
           

摘要

Interstitial pneumonitis is a rare but potentially fatal side effect occurring from 2 weeks to 16 weeks after the initiation of treatment with pegylated interferon alpha and ribavirin for chronic hepatitis C. Herein, we present a 68-year-old man with chronic hepatitis C virus infection who developed interstitial pneumonitis association with pegylated interferon after 36 weeks initiation of pegylated interferon-alpha and ribavirin therapy. He did not recover after discontinuation of pegylated interferon/ribavirin and improved by steroid therapy.
机译:间质性肺炎是一种罕见的但可能致命的副作用,发生于开始使用聚乙二醇化干扰素α和利巴韦林治疗慢性丙型肝炎后的2周至16周。在此,我们介绍了一名68岁的慢性丙型肝炎病毒感染者在开始使用聚乙二醇化干扰素-α和利巴韦林治疗36周后,与聚乙二醇化干扰素发生了间质性肺炎。停用聚乙二醇化干扰素/利巴韦林后,他没有恢复,并通过类固醇疗法得以改善。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号